Contract 75F40122C00112
Synensys, Llc · Department Of Health And Human Services · September 8, 2022
Synensys, Llc was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on September 8, 2022 for $3.68 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Peachtree City, GA. It was awarded under full and open competition. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on May 17, 2023.
Contract details
- PIID
- 75F40122C00112
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Basic Research
- Place of performance
- Peachtree City, GA
- First action
- September 8, 2022
- Latest action
- May 17, 2023
Description
PMWP 214 - IMPROVING THE RELIABILITY, INTEROPERABILITY, AGILITY, AND QUALITY OF LABORATORY DATA EXCHANGES USING SYSTEM SAFETY ENGINEERING AND HIGH RELIABILITY ORGANIZATION METHODS.
Modification timeline
-
May 17, 2023Mod P00003PMWP 214 - IMPROVING THE RELIABILITY, INTEROPERABILITY, AGILITY, AND QUALITY OF LABORATORY DATA EXCHANGES USING SYSTEM SAFETY ENGINEERING AND HIGH RELIABILITY O$1.54M
-
March 7, 2023Mod P00002PMWP 214 - IMPROVING THE RELIABILITY, INTEROPERABILITY, AGILITY, AND QUALITY OF LABORATORY DATA EXCHANGES USING SYSTEM SAFETY ENGINEERING AND HIGH RELIABILITY O$350.0K
-
January 4, 2023Mod P00001PMWP 214 - IMPROVING THE RELIABILITY, INTEROPERABILITY, AGILITY, AND QUALITY OF LABORATORY DATA EXCHANGES USING SYSTEM SAFETY ENGINEERING AND HIGH RELIABILITY O$0
-
September 8, 2022Base awardPMWP 214 - IMPROVING THE RELIABILITY, INTEROPERABILITY, AGILITY, AND QUALITY OF LABORATORY DATA EXCHANGES USING SYSTEM SAFETY ENGINEERING AND HIGH RELIABILITY O$1.78M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | The Boeing Company | 1 | $4.44B |
| 2 | Advanced Technology International | 9 | $3.35B |
| 3 | Amgen USA Inc | 2 | $774.69M |
| 4 | Siga Technologies, Inc. | 1 | $624.44M |
| 5 | Icon Government And Public Health Solutions, Inc. | 16 | $404.80M |
| 6 | Technical Resources International, Inc. | 19 | $395.29M |
| 7 | Allucent Government Services (Us) Llc | 9 | $384.26M |
| 8 | Mapp Biopharmaceutical, Inc. | 7 | $354.24M |
| 9 | Ppd Development Lp | 18 | $331.02M |
| 10 | Albert B. Sabin Vaccine Institute, Inc. (The) | 2 | $305.87M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75F40122C00112?
Contract 75F40122C00112 is a federal contract awarded to Synensys, Llc by Department Of Health And Human Services on September 8, 2022 for $3.68 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 3 times since the base award.
Who won contract 75F40122C00112?
Synensys, Llc won contract 75F40122C00112 from Department Of Health And Human Services.
How much is contract 75F40122C00112 worth?
Contract 75F40122C00112 has obligated $3.68 million to date.